MHRA/CHM ADVICE: CORTICOSTEROIDS: RARE RISK OF CENTRAL
SEROUS CHORIORETINOPATHY WITH LOCAL AS WELL AS SYSTEMIC
ADMINISTRATION (AUGUST 2017)
See Corticosteroids, general use p. 707.
PDF page 1285
→Appendix 1: fluocinolone. quinolones
PDF page 1285
▶Common or very common Ear discomfort. taste altered
▶Uncommon Crying. dizziness. fatigue. flushing. headache
. hearing impairment. increased risk of infection.
irritability. otorrhoea. paraesthesia. skin reactions.
tinnitus. tympanic membrane disorder. vomiting
SIDE-EFFECTS, FURTHER INFORMATION Manufacturer
advises further evaluation of underlying conditions if
otorrhoea persists after a full course, or if at least two
episodes of otorrhoea occur within 6 months.
PDF page 1285
Manufacturer advises use only if potential
benefit outweighs risk—limited information available.
PDF page 1285
Manufacturer advises caution.
PDF page 1285